Filtered By:
Drug: Methamphetamine

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 85 results found since Jan 2013.

We are ‘sitting on a young people’s health time bomb’
Health inequalities compound in marginalised young people making health outcomes much worse Related items fromOnMedica Higher risk of stroke in young people using methamphetamine Widening inequalities jeopardising health of children in Northern Ireland New report reveals 1 in 4 children in UK lives in poverty Self-harm among children and young people on the rise Third of young people with mental health issues stigmatised
Source: OnMedica Latest News - October 17, 2017 Category: UK Health Source Type: news

Isolated persistent acute global amnesia after acute abuse of 3,4-methylenedioxy-methamphetamine (MDMA)
Acute global amnesia can occur, due to bilateral hippocampus dysfunction. Causes include the idiopathic syndrome of transient global amnesia, bilateral posterior circulation stroke,. toxic anoxia due to carbon monoxyde poisoning and substance abuse probably combining hypoxia and direct hippocampal neurotoxicity.
Source: Journal of the Neurological Sciences - January 4, 2018 Category: Neurology Authors: Fabien Hauw, Elodie Meppiel, Olivier Steichen, Pierre-Louis Conan, Jean Capron, Thomas de Broucker Tags: Letter to the Editor Source Type: research

Methamphetamine-induced internal carotid artery vasospasm: A rapidly fatal stroke
Chen Fei Ng, Chia Yin ChongNeurology India 2018 66(3):826-827
Source: Neurology India - May 15, 2018 Category: Neurology Authors: Chen Fei Ng Chia Yin Chong Source Type: research

Psychostimulants play a major role in fatal strokes among young adults
(Wiley) An estimated 76 million people use psychostimulants, which include illicit drugs such as methamphetamine, cocaine, and 3,4-methylenedioxymethamphetamine, as well as prescription stimulants. A new Journal of Forensic Sciences study from Australia is the first to present national data of psychostimulant use in young adults who experienced a fatal stroke.
Source: EurekAlert! - Medicine and Health - April 3, 2019 Category: International Medicine & Public Health Source Type: news

Psychostimulants Tied to 1 in 5 Fatal Strokes in Young Adults Psychostimulants Tied to 1 in 5 Fatal Strokes in Young Adults
Psychostimulants like methamphetamine, cocaine, and MDMA have been tied to a significantly increased risk of fatal stroke in young adults, new research shows.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - April 15, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
Conclusions: This meta-analysis revealed that PD is associated with an increase of CRP levels. CRP might be a risk factor for PD or PD leads to an inflammatory response. Introduction Parkinson's disease (PD) is one of the most complex neuro-degenerative disorders next to Alzheimer's disease. It is characterized by bradykinesia, tremor, rigidity, abnormal postural, and gait (1). PD has been recognized by the selective loss of dopaminergic neurons within the substantia nigra pars compacta, whereas the exact etiology remains elusive (2). Previously, multiple inferences have reviewed the environmental a...
Source: Frontiers in Neurology - April 16, 2019 Category: Neurology Source Type: research

Protective effect of gastrodin against methamphetamine-induced autophagy in human dopaminergic neuroblastoma SH-SY5Y cells via the AKT/mTOR signaling pathway
This study investigates whether METH induces autophagy in the human dopaminergic neuroblastoma cell line SH-SY5Y, then examines the neuroprotective effects of gastrodin against autophagy in METH-treated SH-SY5Y cells. The effects of METH on the protein expressions of autophagy-related genes (LC3B and Beclin-1) were evaluated with and without gastrodin. The presence of autophagosomes in the METH-induced treatment with and without gastrodin is revealed through transmission electron microscopy. Pharmacological intervention was employed to study the role of the AKT/mTOR signaling pathway in the gastrodin-mediated neuroprotecti...
Source: Neuroscience Letters - May 24, 2019 Category: Neuroscience Source Type: research

Methamphetamine ‐related cardiovascular diseases
ConclusionsAwareness is needed as cardiac complications are important causes of morbidity and mortality in patients with MA consumption. Drug abstinence is the mainstay of therapy, cardiac and other complications should be treated according to the respective guidelines. Incompliance to therapy and frequent relapses are the main challenges for successful treatment. Further research is required to improve the understanding of this rapidly increasing cardiomyopathy.
Source: ESC Heart Failure - January 16, 2020 Category: Cardiology Authors: Valentin Schwarzbach, Karsten Lenk, Ulrich Laufs Tags: Review Source Type: research

Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch
Approved food and drug administration (FDA) medications to treat Psychostimulant Use Disorder (PUD) are needed. Both acute and chronic neurological deficits related to the neurophysiological effects of these powerfully addictive drugs can cause stroke and alterations in mood and cognition.
Source: Journal of the Neurological Sciences - November 27, 2020 Category: Neurology Authors: Kenneth Blum, Jean Lud Cadet, Mark S. Gold Tags: Review Article Source Type: research

Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data
Introduction Rising use of methamphetamine is causing significant public health concern in Canada. The biological and behavioural effects of methamphetamine range from wakefulness, vigour and euphoria to adverse physical health outcomes like myocardial infarction, haemorrhagic stroke, arrhythmia and seizure. It can also cause severe psychological complications such as psychosis. National survey data point to increasing rates of methamphetamine use, as well as increasing ease of access and serious methamphetamine-related harms. There is an urgent need for evidence to address knowledge gaps, provide direction to harm reducti...
Source: BMJ Open - October 19, 2022 Category: General Medicine Authors: Nickel, N. C., Enns, J. E., Freier, A., McCulloch, S. C., Chartier, M., Casidsid, H. J. M., Balogun, O. D., Mulhall, D., Dragan, R., Sarkar, J., Bolton, J., Konrad, G., Phillips-Beck, W., Sanguins, J., Shimmin, C., McDonald, N., Mignone, J., Hinds, A., Me Tags: Open access, Public health Source Type: research